PIK3CD and cancer: PI3K has been found to mediate immune evasion by downregulating major histocompatibility complex Class I (MHCI) antigen presentation at the cell surface, therefore decreasing cancer cell recognition by CD8+ cytotoxic T-cells [336,337].